Agios Pharmaceuticals (AGIO) Inventory (2018 - 2026)

Agios Pharmaceuticals' Inventory history runs 8 years deep, the most recent figure standing at $35.1 million for Q1 2026.

• Quarterly Inventory rose 18.52% year-over-year to $35.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.1 million (up 18.52% YoY) and the FY2025 annual result came in at $32.9 million, up 19.21% from the prior year.
• Inventory was $35.1 million for Q1 2026 at Agios Pharmaceuticals, up from $32.9 million in the prior quarter.
• Across five years, Inventory topped out at $35.1 million in Q1 2026 and bottomed at $2.5 million in Q1 2022.
• A 5-year average of $20.3 million and a median of $23.1 million in 2024 frame the typical range for Inventory.
• Annual changes were most pronounced in 2023 — Inventory jumped 357.71% — and 2026, when it climbed 18.52%.
• Agios Pharmaceuticals' Inventory stood at $8.5 million in 2022, then soared by 124.63% to $19.1 million in 2023, then jumped by 44.77% to $27.6 million in 2024, then rose by 19.21% to $32.9 million in 2025, then grew by 6.58% to $35.1 million in 2026.
• Business Quant data shows AGIO's Inventory at $35.1 million in Q1 2026, $32.9 million in Q4 2025, and $32.0 million in Q3 2025.